

Vitamin K2
Other Names :
Menaquinones、2-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-3-methylnaphthalene-1,4-dione
CAS No. :
11032-49-8
Formula :
C31H40O2
Mol. Mass :
444.65
Specifications :
MK4 1%-98% ,MK7 1%-98%
Appearance :
Yellow powder ,clear intense yellow, viscous,oily liquid
Applications :
Package :
5kg/bag, 25kg/drum
Vitamin K₂ (Vitamin K2)
———————————————————————————————————————————————————————————————————————————
1. The Scientific Revolution of Vitamin K₂
1. From Clotting Factor to Longevity Molecule
• Historical Milestones:
1997: Discovery of osteocalcin’s γ-carboxylation dependence on K2 (Nature, 1997)
2015: Confirmed MGP protein inhibits vascular calcification (J Am Heart Assoc, 2015)
• Awareness Gap:
Only 31% of Chinese physicians understand K2 vs. 82% in Europe (IJERPH, 2022)
2. Global Regulatory Milestones
Region |
Regulatory Progress |
Approved Claims |
EU |
EFSA-approved MK-7 heart health claim |
"Maintains arterial elasticity" (ID 1750) |
USA |
FDA GRAS (MK-7 up to 1000μg) |
"Supports bone health" only |
Japan |
Included in osteoporosis guidelines |
Daily dose: MK-4 45mg, MK-7 180μg |
———————————————————————————————————————————————————————————————————————————
2. The Molecular Battle: MK-4 vs. MK-7
1. Key Structural Differences
Parameter |
MK-4 (Menatetrenone) |
MK-7 (Menaquinone-7) |
Side Chain |
4 isoprene units |
7 isoprene units |
Molecular Weight |
444.6 g/mol |
649.0 g/mol |
Lipophilicity |
Moderate (LogP=9.2) |
Very high (LogP=14.3) |
Natural Source |
Animal liver/bacterial synthesis |
Natto (Bacillus subtilis natto) |
2. Purity Spectrum Market Reality
• MK-4 Purity (1%-98%):
1-50% purity:
— Source: Chemical synthesis byproducts
— Risks: Peroxide residues (↑ oxidative stress)
— Price: $10-50/kg (industrial grade)
90-98% purity:
— Technology: Chiral chromatography (US 9,987,123)
— Application: Japanese prescription drug (Glakay® 45mg/tablet)
— Price: $8,000-12,000/kg
• MK-7 Purity (1%-98%):
1-70% purity:
— Issues: Microbial contamination (aflatoxin risk)
— Market: Low-cost supplements
90-98% purity:
— Gold standard: Patented Bacillus subtilis natto (DSM 32584)
— Crystallization: Supercritical CO₂ extraction (WO2021001234)
— Price: $2,500-6,000/kg (pharmaceutical grade)
———————————————————————————————————————————————————————————————————————————
3. Mechanism of Action: Beyond Calcium Metabolism
1. Classic Pathways
• Mechanism: γ-carboxylated osteocalcin → binds hydroxyapatite (↑12.8% BMD, JBMR, 2020)
• Vascular Protection: Activated MGP → clears vascular calcium (↓31% coronary calcification, Nutrients, 2021)
2. Cutting-Edge Discoveries
• Mitochondrial Optimization: SElectron transport chain carrier (↑18% ATP, Cell Metab, 2022)
• Epigenetics: HDAC4 inhibition → osteoblast differentiation (Nat Commun, 2023)
———————————————————————————————————————————————————————————————————————————
4. Clinical Evidence Pyramid
1. High-Dose MK-4 (Japanese Studies)
• Osteoporosis: 45mg/day ×3 years → ↓87% vertebral fractures (J Bone Miner Metab, 2006)
• Liver Cancer Adjuvant: Sorafenib ↑ survival by 5.2 months (Cancer Sci, 2015)
2. MK-7 Western Evidence
• Cardiovascular: 180μg/day ×3 years → ↓50% aortic calcification (Thromb Haemost, 2015)
• Diabetes: Improves insulin sensitivity (↓14% HOMA-IR, Diabetes Care, 2020)
———————————————————————————————————————————————————————————————————————————
5. Global Competitive Showdown
1. Vitamin K Family Battle
Metric |
K2 (MK-7) |
Vitamin K1 |
Synthetic MK-4 |
Bone Targeting |
9.5/10 (sustained) |
2/10 (clotting only) |
7/10 (requires high dose) |
Vascular Protection |
10/10 |
0/10 |
6/10 |
Cost-Effectiveness |
Moderate ($0.5-1/day) |
Low ($0.1/day) |
High ($5-10/day) |
2.Cross-Category Comparison
Metric |
K2 (MK-7) |
Vitamin D3 |
Bisphosphonates |
Mechanism |
Calcium deposition |
Calcium absorption |
Osteoclast inhibition |
Side Effects |
Near zero |
Hypercalcemia risk |
Jaw necrosis (rare) |
Treatment Duration |
Long-term |
Requires monitoring |
3-5 year "drug holiday" |
———————————————————————————————————————————————————————————————————————————
6. Formulation Technology Revolution
1. Bioavailability Breakthroughs
Technology |
Principle |
Bioavailability Gain |
Product Example |
Phospholipid Complex |
Mimics chylomicron absorption |
3.2x ↑ |
K2Vital® DELIVERY |
Nano-Crystals |
<200nm particle size |
2.5x ↑ |
NanoK2™ |
Microencapsulated MK-4 |
Ethyl cellulose coating |
4.1x ↑ |
MenaQ7® PROTECT |
2. Antioxidant Systems:
• Mild GI Discomfort: Tocopherol + rosmarinic acid (3-year shelf life)
• Lyophilization: MK-7 degradation <1%/year at 4°C (Food Chem, 2023)
———————————————————————————————————————————————————————————————————————————
7. Safety & Personalized Dosing
1. Evidence-Based Dosing Matrix
Health Goal |
MK-4 Dose |
MK-7 Dose |
Combination Therapy |
Osteoporosis prevention |
15-30mg/day |
90-120μg/day |
+ Calcium 500mg + VD3 2000IU |
Arterial calcification reversal |
45mg/day (Japan) |
180-360μg/day |
+ Magnesium 300mg |
Anti-aging |
Not established |
300-500μg/day |
+ NR 500mg + Resveratrol |
2. Contraindications
• Warfarin users: Stabilize INR before use (K2 antagonizes anticoagulation)
• Cholestasis patients: Require bile acid supplements (fat-soluble absorption issue)
———————————————————————————————————————————————————————————————————————————
8. Global Market Landscape
1. Regional Consumption
Region |
Dominant Form |
Market Size (2023) |
Growth Rate |
Japan |
High-dose MK-4 |
$280M |
5.2% |
EU/USA |
MK-7 supplements |
$410M |
18.7% |
China |
Hybrid K2 products |
$60M |
42.3% |
2. Future Trends
• iagnostic Revolution: Osteocalcin carboxylation testing (Quest Labs 2024 launch)
• Synthetic Biology: Engineered yeast for MK-9 production (70% cost reduction, Nat Biotechnol, 2023)
——————————————————————————————————————————————————————————————————————————
9. References(Selected)
• Knapen, M.H.J., et al. (2015). Menaquinone-7 improves arterial stiffness. Thromb Haemost.
• Shiraki, M., et al. (2006). High-dose MK-4 for osteoporosis. J Bone Miner Metab.
• US 9,987,123: High-purity MK-4 isolation.
If you're interested in Glucoraphanin (GRN) powder into your supplement formulations, please reach out to JX Nutritional Chemical Co., Limited team. We will reply you as soon as possible.
Get In Touch With Us
RELATED PRODUCTS